{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:16:52Z","timestamp":1789474612785,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s10787-021-00907-7","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T21:29:01Z","timestamp":1641850141000},"page":"313-325","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Montelukast suppresses the development of irritable bowel syndrome phenotype possibly through modulating NF-\u03baB signaling in an experimental model"],"prefix":"10.1007","volume":"30","author":[{"given":"Pariya","family":"Khodabakhsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilgoon","family":"Khoie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad-Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Abdollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Ghazi-Khansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0030-4077","authenticated-orcid":false,"given":"Hamed","family":"Shafaroodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"key":"907_CR1","first-page":"2993","volume":"25","author":"R Abdullayev","year":"2021","unstructured":"Abdullayev R, Makhmudova L (2021) Features of chemical elements in various forms of irritable bowel syndrome. Ann Rom Soc Cell Biol 25:2993\u20133000","journal-title":"Ann Rom Soc Cell Biol"},{"key":"907_CR2","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1053\/gast.2000.19576","volume":"119","author":"ED Al-Chaer","year":"2000","unstructured":"Al-Chaer ED, Kawasaki M, Pasricha PJ (2000) A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology 119:1276\u20131285","journal-title":"Gastroenterology"},{"key":"907_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174196","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Almulaiky YQ, Cruz-Martins N, Batiha GE-S (2021) Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of covid-19: the enigmatic entity. Eur J Pharmacol. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174196","journal-title":"Eur J Pharmacol"},{"key":"907_CR4","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1111\/bph.12665","volume":"171","author":"M B\u00e4ck","year":"2014","unstructured":"B\u00e4ck M, Powell WS, Dahl\u00e9n SE, Drazen JM, Evans JF, Serhan CN, Shimizu T, Yokomizo T, Rovati GE (2014) Update on leukotriene, lipoxin and oxoeicosanoid receptors: iuphar review 7. Br J Pharmacol 171:3551\u20133574","journal-title":"Br J Pharmacol"},{"key":"907_CR5","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1056\/NEJMra1207068","volume":"367","author":"M Camilleri","year":"2012","unstructured":"Camilleri M (2012) Peripheral mechanisms in irritable bowel syndrome. N Engl J Med 367:1626\u20131635","journal-title":"N Engl J Med"},{"key":"907_CR6","doi-asserted-by":"crossref","first-page":"175628481987895","DOI":"10.1177\/1756284819878950","volume":"12","author":"DJ Cangemi","year":"2019","unstructured":"Cangemi DJ, Lacy BE (2019) Management of irritable bowel syndrome with diarrhea: a review of nonpharmacological and pharmacological interventions. Ther Adv Gastroenterol 12:1756284819878950","journal-title":"Ther Adv Gastroenterol"},{"key":"907_CR7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/med.21251","volume":"33","author":"V Capra","year":"2013","unstructured":"Capra V, B\u00e4ck M, Barbieri SS, Camera M, Tremoli E, Rovati GE (2013) Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke. Med Res Rev 33:364\u2013438","journal-title":"Med Res Rev"},{"key":"907_CR8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3329\/medtoday.v24i2.15012","volume":"24","author":"M Chowdhury","year":"2013","unstructured":"Chowdhury M, Uddin M, Das S, Hoque M (2013) Montelukast in allergic rhinitis: a review. Med Today 24:75\u201378","journal-title":"Med Today"},{"key":"907_CR9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.acthis.2008.04.006","volume":"111","author":"E \u00c7ikler","year":"2009","unstructured":"\u00c7ikler E, Ersoy Y, \u00c7etinel \u015e, Ercan F (2009) The leukotriene D4 receptor antagonist, montelukast, inhibits mast cell degranulation in the dermis induced by water avoidance stress. Acta Histochem 111:112\u2013118","journal-title":"Acta Histochem"},{"key":"907_CR10","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3390\/brainsci10110865","volume":"10","author":"RO Cojocariu","year":"2020","unstructured":"Cojocariu RO, Balmus IM, Lefter R, Ababei DC, Ciobica A, Hritcu L, Kamal F, Doroftei B (2020) Behavioral and oxidative stress changes in mice subjected to combinations of multiple stressors relevant to irritable bowel syndrome. Brain Sci 10:865","journal-title":"Brain Sci"},{"key":"907_CR11","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.3389\/fphar.2020.629026","volume":"11","author":"E Colomier","year":"2021","unstructured":"Colomier E, Algera J, Melchior C (2021) Pharmacological therapies and their clinical targets in irritable bowel syndrome with diarrhea. Front Pharmacol 11:2464","journal-title":"Front Pharmacol"},{"key":"907_CR12","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3389\/fpsyt.2019.00714","volume":"10","author":"Y Dong","year":"2019","unstructured":"Dong Y, Baumeister D, Berens S, Eich W, Tesarz J (2019) High rates of non-response across treatment attempts in chronic irritable bowel syndrome: results from a follow-up study in tertiary care. Front Psych 10:714","journal-title":"Front Psych"},{"key":"907_CR13","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1378\/chest.122.4.1497","volume":"122","author":"WH Fee","year":"2002","unstructured":"Fee WH (2002) Irritable bowel syndrome helped by montelukast. Chest J 122:1497\u20131497","journal-title":"Chest J"},{"key":"907_CR14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2016.03.010","volume":"779","author":"B Ghorbanzadeh","year":"2016","unstructured":"Ghorbanzadeh B, Mansouri MT, Sahraei H, Alboghobeish S (2016) Involvement of opioid receptors in the systemic and peripheral antinociceptive actions of montelukast in the animal models of pain. Eur J Pharmacol 779:38\u201345","journal-title":"Eur J Pharmacol"},{"key":"907_CR15","doi-asserted-by":"crossref","first-page":"113957","DOI":"10.18632\/oncotarget.23045","volume":"8","author":"X He","year":"2017","unstructured":"He X, Cui L-H, Wang X-H, Yan Z-H, Li C, Gong S-D, Zheng Y, Luo Z, Wang Y (2017) Modulation of inflammation by toll-like receptor 4\/nuclear factor-kappa b in diarrhea-predominant irritable bowel syndrome. Oncotarget 8:113957","journal-title":"Oncotarget"},{"key":"907_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep18286","volume":"5","author":"KJ Herbst-Robinson","year":"2015","unstructured":"Herbst-Robinson KJ, Liu L, James M, Yao Y, Xie SX, Brunden KR (2015) Inflammatory eicosanoids increase amyloid precursor protein expression via activation of multiple neuronal receptors. Sci Rep 5:1\u201316","journal-title":"Sci Rep"},{"key":"907_CR17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0014-2999(01)01330-9","volume":"429","author":"R Holma","year":"2001","unstructured":"Holma R, Salmenper\u00e4 P, Riutta A, Virtanen I, Korpela R, Vapaatalo H (2001) Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats. Eur J Pharmacol 429:309\u2013318","journal-title":"Eur J Pharmacol"},{"key":"907_CR18","first-page":"455","volume":"58","author":"R Holma","year":"2007","unstructured":"Holma R, Salmenper\u00e4 P, Virtanen I, Vapaatalo H, Korpela R (2007) Prophylactic potential of montelukast against mild colitis induced by dextran sulphate sodium in rats. J Physiol Pharmacol 58:455\u2013467","journal-title":"J Physiol Pharmacol"},{"key":"907_CR19","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s12031-020-01542-7","volume":"70","author":"S Hosseindoost","year":"2020","unstructured":"Hosseindoost S, Hashemizadeh S, Gharaylou Z, Dehpour AR, Javadi SAH, Arjmand B, Hadjighassem M (2020) \u03922-adrenergic receptor stimulation upregulates cx43 expression on glioblastoma multiforme and olfactory ensheathing cells. J Mol Neurosci 70:1451\u20131460","journal-title":"J Mol Neurosci"},{"key":"907_CR20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1742-2094-9-145","volume":"9","author":"X-Q Huang","year":"2012","unstructured":"Huang X-Q, Zhang X-Y, Wang X-R, Yu S-Y, Fang S-H, Lu Y-B, Zhang W-P, Wei E-Q (2012) Transforming growth factor \u03921-induced astrocyte migration is mediated in part by activating 5-lipoxygenase and cysteinyl leukotriene receptor 1. J Neuroinflammation 9:145","journal-title":"J Neuroinflammation"},{"issue":"2","key":"907_CR21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/0194599815580976","volume":"153","author":"I Ince","year":"2015","unstructured":"Ince I, Yoruk O, Ahiskalioglu A, Aksoy M, Dostbil A, Celik M (2015) Does montelukast have an effect on post-tonsillectomy pain control in children? A randomized trial study. Otolaryngol Head Neck Surg 153(2):269\u2013274","journal-title":"Otolaryngol Head Neck Surg"},{"key":"907_CR22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.plefa.2005.02.008","volume":"72","author":"L Kabasakal","year":"2005","unstructured":"Kabasakal L, \u015eener G, \u00c7etinel \u015e, Contuk G, Gedik N, Ye\u011fen B\u00c7 (2005) Burn-induced oxidative injury of the gut is ameliorated by the leukotriene receptor blocker montelukast. Prostaglandins Leukot Essent Fat Acids 72:431\u2013440","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"907_CR23","doi-asserted-by":"crossref","first-page":"120088","DOI":"10.1016\/j.lfs.2021.120088","volume":"287","author":"P Khodabakhsh","year":"2021","unstructured":"Khodabakhsh P, Bazrgar M, Dargahi L, Mohagheghi F, Taei AA, Parvardeh S, Ahmadiani A (2021) Does Alzheimer\u2019s disease stem in the gastrointestinal system? Life Sci 287:120088","journal-title":"Life Sci"},{"key":"907_CR24","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.3748\/wjg.v9.i12.2791","volume":"9","author":"J-H La","year":"2003","unstructured":"La J-H, Kim T-W, Sung T-S, Kang J-W, Kim H-J, Yang I-S (2003) Visceral hypersensitivity and altered colonic motility after subsidence of inflammation in a rat model of colitis. World J Gastroenterol 9:2791\u20132795","journal-title":"World J Gastroenterol"},{"key":"907_CR25","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2007.01.046","volume":"132","author":"T Liebregts","year":"2007","unstructured":"Liebregts T, Adam B, Bredack C, R\u00f6th A, Heinzel S, Lester S, Downie-Doyle S, Smith E, Drew P, Talley NJ (2007) Immune activation in patients with irritable bowel syndrome. Gastroenterology 132:913\u2013920","journal-title":"Gastroenterology"},{"key":"907_CR26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative pcr and the 2 \u0394\u03b4c T method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"907_CR27","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S1081-1206(10)61326-9","volume":"94","author":"S Maeba","year":"2005","unstructured":"Maeba S, Ichiyama T, Ueno Y, Makata H, Matsubara T, Furukawa S (2005) Effect of montelukast on nuclear factor \u03bab activation and proinflammatory molecules. Ann Allergy Asthma Immunol 94:670\u2013674","journal-title":"Ann Allergy Asthma Immunol"},{"key":"907_CR28","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.ejca.2009.12.022","volume":"46","author":"C Magnusson","year":"2010","unstructured":"Magnusson C, Mezhybovska M, L\u00f6rinc E, Fernebro E, Nilbert M, Sj\u00f6lander A (2010) Low expression of cyslt 1 R and high expression of cyslt 2 R mediate good prognosis in colorectal cancer. Eur J Cancer 46:826\u2013835","journal-title":"Eur J Cancer"},{"key":"907_CR29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0378-4274(03)00269-8","volume":"145","author":"AA Mahgoub","year":"2003","unstructured":"Mahgoub AA, El-Medany AA, Hager HH, Mustafa AA, El-Sabah DM (2003) Evaluating the prophylactic potential of zafirlukast against the toxic effects of acetic acid on the rat colon. Toxicol Lett 145:79\u201387","journal-title":"Toxicol Lett"},{"key":"907_CR30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1540\/jsmr.45.15","volume":"45","author":"N Manabe","year":"2009","unstructured":"Manabe N, Tanaka T, Hata J, Kusunoki H, Haruma K (2009) Pathophysiology underlying irritable bowel syndrome-from the viewpoint of dysfunction of autonomic nervous system activity. J Smooth Muscle Res 45:15\u201323","journal-title":"J Smooth Muscle Res"},{"key":"907_CR31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0929-7855(95)00027-N","volume":"12","author":"KM Metters","year":"1995","unstructured":"Metters KM (1995) Leukotriene receptors. J Lipid Mediat Cell Signal 12:413\u2013427","journal-title":"J Lipid Mediat Cell Signal"},{"key":"907_CR32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pathophys.2011.02.003","volume":"18","author":"AM Mohamadin","year":"2011","unstructured":"Mohamadin AM, Elberry AA, Elkablawy MA, Gawad HSA, Al-Abbasi FA (2011) Montelukast, a leukotriene receptor antagonist abrogates lipopolysaccharide-induced toxicity and oxidative stress in rat liver. Pathophysiology 18:235\u2013242","journal-title":"Pathophysiology"},{"key":"907_CR33","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2165\/00003495-200767060-00005","volume":"67","author":"A Nayak","year":"2007","unstructured":"Nayak A, Langdon RB (2007) Montelukast in the treatment of allergic rhinitis. Drugs 67:887\u2013901","journal-title":"Drugs"},{"key":"907_CR34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF01211372","volume":"30","author":"M Nishikawa","year":"1995","unstructured":"Nishikawa M, Hikasa Y, Hori K, Tanida N, Shimoyama T (1995) Effect of leukotriene C 4 D 4 antagonist on colonic damage induced by intracolonic administration of trinitrobenzene sulfonic acid in rats. J Gastroenterol 30:34\u201340","journal-title":"J Gastroenterol"},{"key":"907_CR35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/1440-1681.12188","volume":"41","author":"P Paragomi","year":"2014","unstructured":"Paragomi P, Rahimian R, Kazemi MH, Gharedaghi MH, Khalifeh-Soltani A, Azary S, Javidan AN, Moradi K, Sakuma S, Dehpour AR (2014) Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea-predominant irritable bowel syndrome: role of nitric oxide. Clin Exp Pharmacol Physiol 41:118\u2013126","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"907_CR36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0016-5085(92)91794-5","volume":"102","author":"L Pons","year":"1992","unstructured":"Pons L, Droy-Lefaix M-T, Bueno L (1992) Leukotriene D 4 participates in colonic transit disturbances induced by intracolonic administration of trinitrobenzene sulfonic acid in rats. Gastroenterology 102:149\u2013156","journal-title":"Gastroenterology"},{"key":"907_CR37","first-page":"327","volume":"229","author":"R Porsolt","year":"1977","unstructured":"Porsolt R, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327\u2013336","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"907_CR38","doi-asserted-by":"crossref","first-page":"173502","DOI":"10.1016\/j.ejphar.2020.173502","volume":"885","author":"S Pournajaf","year":"2020","unstructured":"Pournajaf S, Valian N, Shalmani LM, Khodabakhsh P, Jorjani M, Dargahi L (2020) Fingolimod increases oligodendrocytes markers expression in epidermal neural crest stem cells. Eur J Pharmacol 885:173502","journal-title":"Eur J Pharmacol"},{"key":"907_CR39","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.3748\/wjg.v18.i20.2481","volume":"18","author":"H-Y Qin","year":"2012","unstructured":"Qin H-Y, Xiao H-T, Wu JC, Berman BM, Sung JJ, Bian Z-X (2012) Key factors in developing the trinitrobenzene sulfonic acid-induced post-inflammatory irritable bowel syndrome model in rats. World J Gastroenterol WJG 18:2481","journal-title":"World J Gastroenterol WJG"},{"key":"907_CR40","first-page":"379","volume":"34","author":"G Riccioni","year":"2004","unstructured":"Riccioni G, Di Ilio C, Conti P, Theoharides TC, D\u2019orazio N (2004) Advances in therapy with antileukotriene drugs. Ann Clin Lab Sci 34:379\u2013387","journal-title":"Ann Clin Lab Sci"},{"key":"907_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2020.09.013","author":"N Sanghai","year":"2020","unstructured":"Sanghai N, Tranmer GK (2020) Taming the cytokine storm: repurposing montelukast for the attenuation and prophylaxis of severe covid-19 symptoms. Drug Discov Today. https:\/\/doi.org\/10.1016\/j.drudis.2020.09.013","journal-title":"Drug Discov Today"},{"key":"907_CR42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2125.1995.tb05785.x","volume":"40","author":"D Schoors","year":"1995","unstructured":"Schoors D, Smet M, Reiss T, Margolskee D, Cheng H, Larson P, Amin R, Somers G (1995) Single dose pharmacokinetics, safety and tolerability of Mk-0476, a new leukotriene d4-receptor antagonist, in healthy volunteers. Br J Clin Pharmacol 40:277\u2013280","journal-title":"Br J Clin Pharmacol"},{"key":"907_CR43","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1440-1746.2008.05652.x","volume":"24","author":"H Shamshiri","year":"2009","unstructured":"Shamshiri H, Paragomi P, Paydar MJ, Moezi L, Bahadori M, Behfar B, Ardalan FA, Dehpour AR (2009) Antinociceptive effect of chronic lithium on visceral hypersensitivity in a rat model of diarrhea-predominant irritable bowel syndrome: the role of nitric oxide pathway. J Gastroenterol Hepatol 24:672\u2013680","journal-title":"J Gastroenterol Hepatol"},{"key":"907_CR44","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1136\/gut.2007.119446","volume":"56","author":"R Spiller","year":"2007","unstructured":"Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, Jones R, Kumar D, Rubin G, Trudgill N (2007) Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 56:1770\u20131798","journal-title":"Gut"},{"key":"907_CR45","doi-asserted-by":"crossref","first-page":"581","DOI":"10.5056\/jnm15058","volume":"21","author":"TS Sung","year":"2015","unstructured":"Sung TS, La J-H, Kang TM, Kim TW, Yang I-S (2015) Visceral hypersensitivity and altered colonic motility in type 2 diabetic rat. J Neurogastroenterol Motil 21:581","journal-title":"J Neurogastroenterol Motil"},{"key":"907_CR46","doi-asserted-by":"crossref","first-page":"111709","DOI":"10.1016\/j.biopha.2021.111709","volume":"140","author":"AA Taei","year":"2021","unstructured":"Taei AA, Nasoohi S, Hassanzadeh G, Kadivar M, Dargahi L, Farahmandfar M (2021) Enhancement of angiogenesis and neurogenesis by intracerebroventricular injection of secretome from human embryonic stem cell-derived mesenchymal stem cells in ischemic stroke model. Biomed Pharmacother 140:111709","journal-title":"Biomed Pharmacother"},{"key":"907_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/etm.2020.9459","volume":"21","author":"BC Tel","year":"2021","unstructured":"Tel BC, Telli G, Onder S, Nemutlu E, Bozkurt TE (2021) Investigation of the relationship between chronic montelukast treatment, asthma and depression-like behavior in mice. Exp Ther Med 21:1\u20131","journal-title":"Exp Ther Med"},{"key":"907_CR48","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.4049\/jimmunol.1100333","volume":"187","author":"L Wang","year":"2011","unstructured":"Wang L, Du C, Lv J, Wei W, Cui Y, Xie X (2011) Antiasthmatic drugs targeting the cysteinyl leukotriene receptor 1 alleviate central nervous system inflammatory cell infiltration and pathogenesis of experimental autoimmune encephalomyelitis. J Immunol 187:2336\u20132345","journal-title":"J Immunol"},{"key":"907_CR49","first-page":"52","volume":"42","author":"H Wang","year":"2013","unstructured":"Wang H, Shi Q, Shi W, Zhang X, Wang X, Zhang L, Fang S, Lu Y, Zhang W, Wei E (2013) Expression and distribution of cysteinyl leukotriene receptors cyslt1r and cyslt2r, and gpr17 in brain of parkinson disease model mice. Zhejiang da xue xue bao. Yi xue ban= journal of zhejiang university. Med Sci 42:52\u201360","journal-title":"Med Sci"},{"issue":"1","key":"907_CR50","first-page":"1","volume":"5","author":"S Wu","year":"2015","unstructured":"Wu S, Zhu X, Jin Z, Tong X, Zhu L, Hong X, Zhu X, Liu P, Shen W (2015) The protective role of montelukast against intestinal ischemia-reperfusion injury in rats. Sci Rep 5(1):1\u20139","journal-title":"Sci Rep"},{"key":"907_CR51","first-page":"31","volume":"73","author":"G-L Yu","year":"2004","unstructured":"Yu G-L, Wei E-Q, Zhang S-H, Xu H-M, Chu L-S, Zhang W-P, Zhang Q, Chen Z, Mei R-H, Zhao M-H (2004) Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose-and time-dependently protects against focal cerebral ischemia in mice. Pharmacology 73:31\u201340","journal-title":"Pharmacology"},{"key":"907_CR52","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2005.06.046","volume":"1053","author":"G-L Yu","year":"2005","unstructured":"Yu G-L, Wei E-Q, Wang M-L, Zhang W-P, Zhang S-H, Weng J-Q, Chu L-S, Fang S-H, Zhou Y, Chen Z (2005) Pranlukast, a cysteinyl leukotriene receptor-1 antagonist, protects against chronic ischemic brain injury and inhibits the glial scar formation in mice. Brain Res 1053:116\u2013125","journal-title":"Brain Res"},{"key":"907_CR53","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/aps.2013.130","volume":"35","author":"S-Y Yu","year":"2014","unstructured":"Yu S-Y, Zhang X-Y, Wang X-R, Xu D-M, Chen L, Zhang L-H, Fang S-H, Lu Y-B, Zhang W-P, Wei E-Q (2014) Cysteinyl leukotriene receptor 1 mediates ltd4-induced activation of mouse microglial cells in vitro. Acta Pharmacol Sin 35:33\u201340","journal-title":"Acta Pharmacol Sin"},{"key":"907_CR54","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00213-015-4136-2","volume":"233","author":"X-B Yu","year":"2016","unstructured":"Yu X-B, Dong R-R, Wang H, Lin J-R, An Y-Q, Du Y, Tang S-S, Hu M, Long Y, Sun H-B (2016) Knockdown of hippocampal cysteinyl leukotriene receptor 1 prevents depressive behavior and neuroinflammation induced by chronic mild stress in mice. Psychopharmacology 233:1739\u20131749","journal-title":"Psychopharmacology"},{"key":"907_CR55","first-page":"1341","volume":"25","author":"Y-J Zhang","year":"2004","unstructured":"Zhang Y-J, Zhang L, Wang S-B, Shen H-H, Wei E-Q (2004) Montelukast modulates lung cyslt (1) receptor expression and eosinophilic inflammation in asthmatic mice. Acta Pharmacol Sin 25:1341\u20131346","journal-title":"Acta Pharmacol Sin"},{"key":"907_CR56","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1213\/ANE.0000000000000174","volume":"118","author":"C Zhou","year":"2014","unstructured":"Zhou C, Shi X, Huang H, Zhu Y, Wu Y (2014) Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa b in a rat model of chronic constriction injury. Anesth Analg 118:1090\u20131096","journal-title":"Anesth Analg"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-021-00907-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-021-00907-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-021-00907-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T13:53:34Z","timestamp":1674395614000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-021-00907-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["907"],"URL":"https:\/\/doi.org\/10.1007\/s10787-021-00907-7","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]},"assertion":[{"value":"25 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures in the present study were carried out in accordance with the NIH guide for the care and use of laboratory animals (National Institutes of Health Publication #85-23) and the institutional guidelines for animal care and use (Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences (TUMS) (ethics approval code: IR.TUMS.MEDICINE.REC.1399.183).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}